{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:47:14Z","timestamp":1780656434845,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["U01CA239522"],"award-info":[{"award-number":["U01CA239522"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canlet.2025.217753","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T14:19:48Z","timestamp":1745763588000},"page":"217753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cyst fluid proteins stratify malignant risk of intraductal papillary mucinous neoplasm of the pancreas"],"prefix":"10.1016","volume":"624","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0877-410X","authenticated-orcid":false,"given":"Chunliang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5822-2894","authenticated-orcid":false,"given":"Amber","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Irajizad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7569-7971","authenticated-orcid":false,"given":"Michele","family":"Yip-Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangbing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney R.","family":"Smith-Kinnaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3659-4523","authenticated-orcid":false,"given":"Thoa","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-5938","authenticated-orcid":false,"given":"James P.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8710-7131","authenticated-orcid":false,"given":"Kim-Anh","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Fahrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3835-4464","authenticated-orcid":false,"given":"John M.","family":"DeWitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Hanash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Max","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2179-2388","authenticated-orcid":false,"given":"Jianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.canlet.2025.217753_bib3","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","article-title":"A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas","volume":"39","author":"Basturk","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MPA.0000000000001205","article-title":"Prevalence of asymptomatic intraductal papillary mucinous neoplasms in healthy and ill populations detected by ultrasonography: a single-center study of 6353 outpatients","volume":"48","author":"Ricci","year":"2019","journal-title":"Pancreas"},{"issue":"51","key":"10.1016\/j.canlet.2025.217753_bib5","article-title":"Incidental pancreatic cystic neoplasms in an asymptomatic healthy population of 21,745 individuals: large-scale, single-center cohort study","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine (Baltim.)"},{"issue":"5","key":"10.1016\/j.canlet.2025.217753_bib6","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"Tanaka","year":"2017","journal-title":"Pancreatology"},{"issue":"5","key":"10.1016\/j.canlet.2025.217753_bib7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/gutjnl-2018-316027","article-title":"European evidence-based guidelines on pancreatic cystic neoplasms","volume":"67","year":"2018","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.canlet.2025.217753_bib8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cgh.2008.04.005","article-title":"Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm","volume":"6","author":"Tang","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.canlet.2025.217753_bib9","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/j.1572-0241.2007.01224.x","article-title":"Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients","volume":"102","author":"Pelaez-Luna","year":"2007","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3892\/br.2014.376","article-title":"Serum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis","volume":"3","author":"Wang","year":"2015","journal-title":"Biomed Rep"},{"issue":"3","key":"10.1016\/j.canlet.2025.217753_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000490137","article-title":"Cyst fluid biomarkers - diagnosis and prediction of malignancy for cystic lesions of the pancreas","volume":"34","author":"Raman","year":"2018","journal-title":"Visc. Med."},{"issue":"2","key":"10.1016\/j.canlet.2025.217753_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3892\/ol.2012.1071","article-title":"Pancreatic cyst fluid analysis for differential diagnosis between benign and malignant lesions","volume":"5","author":"Talar-Wojnarowska","year":"2013","journal-title":"Oncol. Lett."},{"issue":"16","key":"10.1016\/j.canlet.2025.217753_bib13","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1158\/1078-0432.CCR-14-0513","article-title":"Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts","volume":"20","author":"Singhi","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.canlet.2025.217753_bib14","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00595-019-01797-7","article-title":"Clinical assessment of the GNAS mutation status in patients with intraductal papillary mucinous neoplasm of the pancreas","volume":"49","author":"Ohtsuka","year":"2019","journal-title":"Surg. Today"},{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12014-023-09424-x","article-title":"Mass spectrometry-based proteomics as an emerging tool in clinical laboratories","volume":"20","author":"Birhanu","year":"2023","journal-title":"Clin. Proteom."},{"issue":"2","key":"10.1016\/j.canlet.2025.217753_bib16","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1097\/MPA.0b013e318193a08f","article-title":"Proteomic analyses of pancreatic cyst fluids","volume":"38","author":"Ke","year":"2009","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.canlet.2025.217753_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.critrevonc.2015.07.006","article-title":"Proteomics in cancer research: are we ready for clinical practice?","volume":"96","author":"Maes","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"9","key":"10.1016\/j.canlet.2025.217753_bib18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nrc2918","article-title":"The grand challenge to decipher the cancer proteome","volume":"10","author":"Hanash","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2025.217753_bib19","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1021\/pr2000557","article-title":"Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts","volume":"10","author":"Cuoghi","year":"2011","journal-title":"J. Proteome Res."},{"issue":"16","key":"10.1016\/j.canlet.2025.217753_bib20","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1158\/0008-5472.CAN-14-2896","article-title":"Discovery and validation of biomarkers that distinguish mucinous and nonmucinous pancreatic cysts","volume":"75","author":"Park","year":"2015","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1559-0275-9-14","article-title":"Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers","volume":"9","author":"Kristjansdottir","year":"2012","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.canlet.2025.217753_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12014-018-9193-1","article-title":"Quantitative proteomic analysis of pancreatic cyst fluid proteins associated with malignancy in intraductal papillary mucinous neoplasms","volume":"15","author":"Do","year":"2018","journal-title":"Clin. Proteom."},{"issue":"9","key":"10.1016\/j.canlet.2025.217753_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092383","article-title":"Marker identification of the grade of dysplasia of intraductal papillary mucinous neoplasm in pancreatic cyst fluid by quantitative proteomic profiling","volume":"12","author":"Do","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"610","key":"10.1016\/j.canlet.2025.217753_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aax0715","article-title":"Hypusine biosynthesis in beta cells links polyamine metabolism to facultative cellular proliferation to maintain glucose homeostasis","volume":"12","author":"Levasseur","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2025.217753_bib25","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.RA120.002384","article-title":"Proteomic analyses identify differentially expressed proteins and pathways between low-risk and high-risk subtypes of early-stage lung adenocarcinoma and their prognostic impacts","volume":"20","author":"Zhou","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"issue":"4","key":"10.1016\/j.canlet.2025.217753_bib26","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1053\/j.gastro.2020.11.052","article-title":"Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection","volume":"160","author":"Fahrmann","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.canlet.2025.217753_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.228","article-title":"OmicShare tools: a zero-code interactive online platform for biological data analysis and visualization","volume":"3","author":"Mu","year":"2024","journal-title":"Imeta"},{"issue":"W1","key":"10.1016\/j.canlet.2025.217753_bib28","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.gastro.2010.10.009","article-title":"CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis","volume":"140","author":"Hiraoka","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac558","article-title":"GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels","volume":"24","author":"Liu","year":"2023","journal-title":"Brief. Bioinform."},{"issue":"4","key":"10.1016\/j.canlet.2025.217753_bib32","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1096\/fj.201801907R","article-title":"Dynamic membrane proteome of adipogenic and myogenic precursors in skeletal muscle highlights EPHA2 may promote myogenic differentiation through ERK signaling","volume":"33","author":"Zhang","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.canlet.2025.217753_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.111838","article-title":"Proteomic characteristics and identification of PM(2.5)-induced differentially expressed proteins in hepatocytes and c-Myc silenced hepatocytes","volume":"209","author":"Qin","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12916-023-03048-6","article-title":"Evidence of questionable research practices in clinical prediction models","volume":"21","author":"White","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.canlet.2025.217753_bib35","article-title":"Evaluation of clinical prediction models (part 1): from development to external validation","volume":"384","author":"Collins","year":"2024","journal-title":"Br. Med. J."},{"issue":"8","key":"10.1016\/j.canlet.2025.217753_bib36","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1158\/2159-8290.CD-22-1200","article-title":"Spatial transcriptomics of intraductal papillary mucinous neoplasms of the pancreas identifies NKX6-2 as a driver of gastric differentiation and indolent biological potential","volume":"13","author":"Sans","year":"2023","journal-title":"Cancer Discov."},{"issue":"16","key":"10.1016\/j.canlet.2025.217753_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612604","article-title":"Screening of exosome-derived proteins and their potential as biomarkers in diagnostic and prognostic for pancreatic cancer","volume":"24","author":"Marin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.canlet.2025.217753_bib38","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41419-021-04258-7","article-title":"Extracellular vesicles in pancreatic cancer progression and therapies","volume":"12","author":"Chang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12943-020-01245-y","article-title":"The involvement of exosomes in the diagnosis and treatment of pancreatic cancer","volume":"19","author":"Ariston Gabriel","year":"2020","journal-title":"Mol. Cancer"},{"issue":"12 Pt 1","key":"10.1016\/j.canlet.2025.217753_bib40","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-0578-03","article-title":"N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma","volume":"10","author":"Nakajima","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2025.217753_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cells9041040","article-title":"E-Cadherin in pancreatic ductal adenocarcinoma: a multifaceted actor during emt","volume":"9","author":"Sommariva","year":"2020","journal-title":"Cells"},{"issue":"1\u20132","key":"10.1016\/j.canlet.2025.217753_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0960-7404(01)00018-4","article-title":"Ubiquitin proteasome pathway: implications and advances in cancer therapy","volume":"10","author":"Shah","year":"2001","journal-title":"Surg. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4251\/wjgo.v14.i1.38","article-title":"Proteasome regulators in pancreatic cancer","volume":"14","author":"Murugan","year":"2022","journal-title":"World J. Gastrointest. Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217753_bib44","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1073\/pnas.1424907112","article-title":"Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk","volume":"112","author":"Feng","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"2","key":"10.1016\/j.canlet.2025.217753_bib45","first-page":"55","article-title":"Considering the role of pyruvate in tumor cells during hypoxia","volume":"1796","author":"Roudier","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40170-021-00256-7","article-title":"Pyruvate carboxylase and cancer progression","volume":"9","author":"Kiesel","year":"2021","journal-title":"Cancer Metabol."},{"issue":"24","key":"10.1016\/j.canlet.2025.217753_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417523","article-title":"Functional and potential therapeutic implication of MicroRNAs in pancreatic cancer","volume":"24","author":"Pal","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217753_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1355064","article-title":"The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers","volume":"14","author":"Jafari","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217753_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12935-020-01185-z","article-title":"MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma","volume":"20","author":"Dai","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"16","key":"10.1016\/j.canlet.2025.217753_bib50","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","article-title":"Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.canlet.2025.217753_bib51","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.1073\/pnas.1301022110","article-title":"IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner","volume":"110","author":"Liu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"13","key":"10.1016\/j.canlet.2025.217753_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137311","article-title":"Interleukin 15 in cell-based cancer immunotherapy","volume":"23","author":"Zhou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.canlet.2025.217753_bib53","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/cncr.21783","article-title":"Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray","volume":"106","author":"Chung","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2025.217753_bib54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006676-200208000-00001","article-title":"Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor","volume":"25","author":"Hoshida","year":"2002","journal-title":"Pancreas"},{"key":"10.1016\/j.canlet.2025.217753_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.692136","article-title":"A pan-cancer analysis of the oncogenic role of twinfilin actin binding protein 1 in human tumors","volume":"11","author":"Huo","year":"2021","journal-title":"Front. Oncol."},{"issue":"42","key":"10.1016\/j.canlet.2025.217753_bib56","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.3748\/wjg.v25.i42.6311","article-title":"MicroRNA-30c inhibits pancreatic cancer cell proliferation by targeting twinfilin 1 and indicates a poor prognosis","volume":"25","author":"Sun","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"20","key":"10.1016\/j.canlet.2025.217753_bib57","doi-asserted-by":"crossref","first-page":"8860","DOI":"10.18632\/aging.102307","article-title":"Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1","volume":"11","author":"Hua","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.canlet.2025.217753_bib58","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.21037\/jtd-23-395","article-title":"Overexpression of TWF1 promotes lung adenocarcinoma progression and is associated with poor prognosis in cancer patients through the MMP1 signaling pathway","volume":"15","author":"Zhai","year":"2023","journal-title":"J. Thorac. Dis."},{"issue":"7","key":"10.1016\/j.canlet.2025.217753_bib59","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300248R","article-title":"TWF1 induces autophagy and accelerates malignant phenotype in lung adenocarcinoma via inhibiting the cAMP signaling pathway","volume":"37","author":"Wang","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.canlet.2025.217753_bib60","doi-asserted-by":"crossref","DOI":"10.1177\/11779322231186719","article-title":"Identification and interaction analysis of molecular markers in pancreatic ductal adenocarcinoma by bioinformatics and next-generation sequencing data analysis","volume":"17","author":"Giriyappagoudar","year":"2023","journal-title":"Bioinf. Biol. Insights"},{"issue":"7","key":"10.1016\/j.canlet.2025.217753_bib61","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ueg2.12449","article-title":"Monitoring Ca19-9 during pancreatic cyst surveillance: better safe than sorry?","volume":"11","author":"Perri","year":"2023","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib62","doi-asserted-by":"crossref","first-page":"8820","DOI":"10.1038\/s41598-020-65720-8","article-title":"Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.canlet.2025.217753_bib63","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/00365521.2020.1753109","article-title":"Blood-based markers for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas - what's beyond the horizon?","volume":"55","author":"Midlov","year":"2020","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.canlet.2025.217753_bib64","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.gastro.2019.05.014","article-title":"Cross validation of the monoclonal antibody das-1 in identification of high-risk mucinous pancreatic cystic lesions","volume":"157","author":"Das","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.canlet.2025.217753_bib65","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41392-023-01645-8","article-title":"Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm","volume":"8","author":"Cui","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.canlet.2025.217753_bib66","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1200\/JCO.2017.73.7288","article-title":"Highly accurate identification of cystic precursor lesions of pancreatic cancer through targeted mass spectrometry: a phase IIc diagnostic study","volume":"36","author":"Jabbar","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.canlet.2025.217753_bib67","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/pmic.201600044","article-title":"Multiple testing corrections in quantitative proteomics: a useful but blunt tool","volume":"16","author":"Pascovici","year":"2016","journal-title":"Proteomics"},{"issue":"9","key":"10.1016\/j.canlet.2025.217753_bib68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4251\/wjgo.v6.i9.311","article-title":"Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas","volume":"6","author":"Castellano-Megias","year":"2014","journal-title":"World J. Gastrointest. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T18:29:35Z","timestamp":1747420175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525003192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":66,"alternative-id":["S0304383525003192"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217753","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyst fluid proteins stratify malignant risk of intraductal papillary mucinous neoplasm of the pancreas","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217753"}}